NOT-AI-21-036: Notice of Early Expiration of NOT-AI-20-065 Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2

Notice of Early Expiration of NOT-AI-20-065 “Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2”

Notice Number:

NOT-AI-21-036

Key Dates

Release Date:

February 17, 2021

Related Announcements

NOT-AI-20-065 - Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2

Issued by

National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

The purpose of this Notice is to inform the extramural community of the early expiration of NOT-AI-20-065, “Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2” effective March 15, 2021. Applications will no longer be accepted in response to this NOSI after the March 14, 2021 Due Date.

Inquiries

Please direct all inquiries to:

Sonnie Kim, M.S.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3287
[email protected]